highlighting a subset of tnbc for targeted therapy
Published 5 years ago • 119 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:28
recent developments in treating tnbc with targeted therapies
-
1:58
targeted therapy in tnbc
-
1:17
recognizing subsets of triple-negative breast cancer
-
1:26
tnbc: the targeted therapy era
-
1:15
clinical implications of progress in tnbc therapies
-
1:13
opportunities for novel targets or therapies in tnbc
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
3:50
clinical approach to triple-negative breast cancer
-
1:16:56
navigating the integration of trop2-targeted therapy in tnbc and hr , her2- breast cancer
-
2:46
de-escalation of therapy in early-stage tnbc
-
5:53
treating early-stage tnbc
-
4:23
a new drug could become one of the first targeted treatments for triple-negative breast cancer
-
1:58
promising novel approaches to the treatment of tnbc
-
3:22
recognizing the complexity of tnbc
-
7:20
ar-targeted therapy and immunotherapy for tnbc
-
22:54
testing, treating, and targeting triple negative breast cancer | 2023 west oncology conference
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute